LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 52.27 | 770.25 | 7964 | 7058 | 1.1282 | 1.0769 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 52.27 | 770.25 | 7444 | 7058 | 1.0546 | 1.0335 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 54.49 | 770.25 | 8532 | 7555 | 1.1292 | 1.0752 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 54.49 | 770.25 | 7961 | 7555 | 1.0537 | 1.0320 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 56.71 | 770.25 | 8998 | 8001 | 1.1245 | 1.0707 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 56.71 | 770.25 | 8411 | 8001 | 1.0512 | 1.0298 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 58.94 | 770.25 | 9559 | 8444 | 1.1320 | 1.0731 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 58.94 | 770.25 | 8916 | 8444 | 1.0559 | 1.0317 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 61.16 | 770.25 | 10005 | 8892 | 1.1252 | 1.0680 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 61.16 | 770.25 | 9338 | 8892 | 1.0502 | 1.0279 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 63.39 | 770.25 | 10547 | 9326 | 1.1309 | 1.0696 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 63.39 | 770.25 | 9741 | 9326 | 1.0445 | 1.0243 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 65.61 | 770.25 | 10972 | 9736 | 1.1270 | 1.0664 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 65.61 | 770.25 | 10169 | 9736 | 1.0445 | 1.0239 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 67.83 | 770.25 | 11239 | 10078 | 1.1152 | 1.0596 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 67.83 | 770.25 | 10582 | 10078 | 1.0500 | 1.0265 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 70.05 | 770.25 | 11728 | 10413 | 1.1262 | 1.0643 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 70.05 | 770.25 | 10871 | 10413 | 1.0439 | 1.0230 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 72.27 | 770.25 | 11944 | 10730 | 1.1130 | 1.0572 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 72.27 | 770.25 | 11235 | 10730 | 1.0470 | 1.0243 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 74.50 | 770.25 | 12220 | 10991 | 1.1118 | 1.0560 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 74.50 | 770.25 | 11557 | 10991 | 1.0514 | 1.0263 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.75 | 770.25 | 12498 | 11262 | 1.1097 | 1.0545 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.75 | 770.25 | 11852 | 11262 | 1.0523 | 1.0265 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.98 | 770.25 | 12844 | 11518 | 1.1151 | 1.0566 | MN20160304_L02 | L17 |